Acetylsalicylic acid Completed Phase 2 Trials for High Risk Essential Thrombocythemia / High Risk Polycythemia Vera Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01259817Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)